RFS
VRTX icon

Rockefeller Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Rockefeller Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,558
Closed -$337K – 588
2014
Q2 		$337K Sell
3,558
-2,476
-41% -$174K 0.01% 296
2014
Q1 		$427K Sell
6,034
-2,768
-31% -$219K 0.01% 270
2013
Q4 		$654K Buy
8,802
+67
+0.8% +$4.67K 0.01% 250
2013
Q3 		$662K Sell
8,735
-187
-2% -$14.9K 0.02% 251
2013
Q2 		$714K Buy
+8,922
New +$657K 0.02% 235

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Rockefeller Financial Services's VRTX Position: Q3 2014 in Review

Rockefeller Financial Services sold out of Vertex Pharmaceuticals (VRTX) in Q3 2014, closing a stake of 3,558 shares — an estimated $337K sold.

Rockefeller Financial Services first reported a position in VRTX in Q2 2013 and held it in 5 quarters. The position peaked at $714K in Q2 2013. 431 funds tracked by Wall St. Rank hold VRTX as of Q3 2014.

  • Rockefeller Financial Services reported no remaining Vertex Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Rockefeller Financial Services sold 3,558 Vertex Pharmaceuticals shares in Q3 2014, an estimated $337K.
  • Rockefeller Financial Services first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Rockefeller Financial Services's Vertex Pharmaceuticals position peaked at $714K in Q2 2013.
  • 431 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2014.

Based on Rockefeller Financial Services's 13F filing for Q3 2014, filed 5 Nov 2014.